Bongo: Mr. Donatus Akamugri Atanga, the Upper East Regional Minister, has appealed to Chiefs in the area to support and guide him in fulfilling his mandate for the region’s development. He highlighted the essential roles Chiefs play in nation-building…
Month: February 2025
Mavenir and OXIO Powering the Next Generation of MVNOs
OXIO’s Telecom-as-a-Service Platform integrates Mavenir Packet Core, IMS and Messaging solutions on Amazon Web Services for enhanced agility RICHARDSON, Texas, Feb. 26, 2025 (GLOBE NEWSWIRE) — Mavenir, the cloud-native network infrastructure provider building the future of networks, today announced that it has been selected by OXIO, a leading Telecom-as-a-Service (TaaS) company, for Packet Core, IMS […]
Mavenir and OXIO Powering the Next Generation of MVNOs
OXIO’s Telecom-as-a-Service Platform integrates Mavenir Packet Core, IMS and Messaging solutions on Amazon Web Services for enhanced agility RICHARDSON, Texas, Feb. 26, 2025 (GLOBE NEWSWIRE) — Mavenir, the cloud-native network infrastructure provider building the future of networks, today announced that it has been selected by OXIO, a leading Telecom-as-a-Service (TaaS) company, for Packet Core, IMS […]
Mavenir and O2 Telefónica Germany Strengthen Partnership with Multi-Year IMS Contract Extension for Cloud-Native IMS Services
New five-year contract with Mavenir powering O2 Telefónica to transition its 4G/5G voice services to latest cloud-native technology MUNICH and BONN, Germany, Feb. 26, 2025 (GLOBE NEWSWIRE) — Mavenir, the cloud-native network infrastructure provider building the future of networks, today announces that it has strengthened its long-term partnership with Telefónica and its global operating companies, […]
IAVI and Biofabri/Zendal Announce First Vaccinations in the IMAGINE Clinical Trial, a Large-scale Safety and Efficacy Trial of the Tuberculosis Vaccine Candidate MTBVAC
Tuberculosis (TB) is the world’s deadliest infectious disease, killing 1.25 million people in 2023.MTBVAC is a promising vaccine candidate being evaluated in the IMAGINE trial, a large-scale safety and efficacy trial evaluating the prevention of TB dis…